Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelets vs Fibrinogen for Bleeding in Pediatric Heart Surgery
NCT04807621Phase 2Unknown
- Sponsor
- Sahlgrenska University Hospital
- Start
- Mar 2018
- Primary completion
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Fibrinogen human in hemorrhage (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: HEPTEM-A10. Status: unknown.
02
Drugs
Fibrinogen human
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT04807621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04807621.